Published on GHDx (https://ghdx.healthdata.org.)

Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 22 factorial randomised controlled trial

General Info

Geography 
Hồ Chí Minh
Viet Nam (VNM)
Coverage type 
Country
Time period covered 
January, 2017 - December, 2019
Data type
Scientific literature
Keywords 
Incidence, Mortality, Tetanus

Citation

Authors 
Van Hao N, Loan HT, Yen LM, Kestelyn E, Hong DD, Thuy DB, Nguyen NT, Duong HTH, Thuy TTD, Nhat PTH, Khanh PNQ, Dung NTP, Phu NH, Phong NT, Lieu PT, Tuyen PT, Hanh BTB, Nghia HDT, Oanh PKN, Tho PV, Tan Thanh T, Turner HC, van Doorn HR, Van Tan L, Wyncoll D, Day NP, Geskus RB, Thwaites GE, Van Vinh Chau N, Thwaites CL
Journal 
Lancet Glob Health
Pages 
e862-e872
Publication year 
2022
Suggested citation 
Van Hao N, Loan HT, Yen LM, Kestelyn E, Hong DD, Thuy DB, Nguyen NT, Duong HTH, Thuy TTD, Nhat PTH, Khanh PNQ, Dung NTP, Phu NH, Phong NT, Lieu PT, Tuyen PT, Hanh BTB, Nghia HDT, Oanh PKN, Tho PV, Tan Thanh T, Turner HC, van Doorn HR, Van Tan L, Wyncoll D, Day NP, Geskus RB, Thwaites GE, Van Vinh Chau N, Thwaites CL. Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 22 factorial randomised controlled trial. Lancet Glob Health. 2022; 10(6): e862-e872.
Source URL:https://ghdx.healthdata.org./record/human-versus-equine-intramuscular-antitoxin-or-without-human-intrathecal-antitoxin-treatment#comment-0